Literature DB >> 19086081

Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community.

Prachi Mehta1, George D Mellick, Dominic B Rowe, Glenda M Halliday, Michael M Jones, Neil Manwaring, Himesha Vandebona, Peter A Silburn, Jie Jin Wang, Paul Mitchell, Carolyn M Sue.   

Abstract

MtDNA haplogroups J and K have been associated with a decreased risk of developing Parkinson's disease (PD). To confirm this finding, we compared the distribution of mtDNA haplogroups J and K in a large sample of Australian patients with PD (n = 890) to population-based controls (n = 3,491). We assigned subjects to haplogroups J or K using standard PCR/RFLP techniques. Of the 890 subjects with PD, 10.6% were haplogroup J (95% CI 8.6-12.8, n = 94) and 7.1% were haplogroup K (95% CI 5.5-8.9, n = 63). In our controls, 10.2% belonged to haplogroup J (95% CI 9.2-11.2, n = 356), and 7.8% were in haplogroup K (95% CI 6.9-8.7, n = 272). There was no significant difference in the prevalence of mtDNA haplogroup J or K in PD patients compared to population-based controls. Our findings indicate that mtDNA haplogroups J and K are not associated with a lower risk of PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19086081     DOI: 10.1002/mds.22389

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

2.  Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Authors:  David K Simon; Nathan Pankratz; Diane K Kissell; Michael W Pauciulo; Cheryl A Halter; Alice Rudolph; Ronald F Pfeiffer; William C Nichols; Tatiana Foroud
Journal:  BMC Med Genet       Date:  2010-04-01       Impact factor: 2.103

3.  Inherited and somatic mitochondrial DNA mutations in Guam amyotrophic lateral sclerosis and parkinsonism-dementia.

Authors:  Dana M Reiff; Rita Spathis; Chim W Chan; Miguel G Vilar; Krithivasan Sankaranarayanan; Daniel Lynch; Emily Ehrlich; Samantha Kerath; Risana Chowdhury; Leah Robinowitz; J Koji Lum; Ralph M Garruto
Journal:  Neurol Sci       Date:  2011-08-06       Impact factor: 3.307

Review 4.  The role of mitochondria in neurodegenerative diseases.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Maria Sofia Cotelli; Valentina Vielmi; Alice Todeschini; Valeria Gregorelli; Paola Tonin; Giuliano Tomelleri; Alessandro Padovani
Journal:  J Neurol       Date:  2011-05-22       Impact factor: 4.849

5.  Whole genome sequencing and novel candidate genes for CAKUT and altered nephrogenesis in the HSRA rat.

Authors:  Kurt C Showmaker; Meredith B Cobb; Ashley C Johnson; Wenyu Yang; Michael R Garrett
Journal:  Physiol Genomics       Date:  2019-12-16       Impact factor: 3.107

6.  Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER.

Authors:  Emily R Holzinger; Todd Hulgan; Ronald J Ellis; David C Samuels; Marylyn D Ritchie; David W Haas; Asha R Kallianpur; Cinnamon S Bloss; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina M Marra; Justin C McArthur; J Allen McCutchan; Susan Morgello; David M Simpson; Donald R Franklin; Debralee Rosario; Doug Selph; Scott Letendre; Igor Grant
Journal:  J Neurovirol       Date:  2012-10-17       Impact factor: 2.643

Review 7.  Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

Authors:  Amy Reeve; Eve Simcox; Doug Turnbull
Journal:  Ageing Res Rev       Date:  2014-02-03       Impact factor: 10.895

8.  Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease.

Authors:  Gavin Hudson; Mike Nalls; Jonathan R Evans; David P Breen; Sophie Winder-Rhodes; Karen E Morrison; Huw R Morris; Caroline H Williams-Gray; Roger A Barker; Andrew B Singleton; John Hardy; Nicholas E Wood; David J Burn; Patrick F Chinnery
Journal:  Neurology       Date:  2013-05-03       Impact factor: 9.910

9.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

Review 10.  Brain Mitochondria, Aging, and Parkinson's Disease.

Authors:  Mario Rango; Nereo Bresolin
Journal:  Genes (Basel)       Date:  2018-05-11       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.